NEW DELHI (Reuters) – Indian drugs regulators have taken action against 105 pharmaceutical companies after a risk-based inspection and audit of manufacturing plants, the health minister said on Tuesday.
The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas. The minister said production has been stopped at 31 companies while product licence cancellations or suspensions have been issued against a further 50 companies.
(Reporting by Shivam Patel; Editing by David Goodman)
